INSANE: Applied genetic | Rare Historical Photos

Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2022

Upgrades

Benzinga · Oct 4, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022

Upgrades

Benzinga · Sep 29, 2022

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Benzinga · Jul 26, 2022